(Q43034294)

12 November 2017

title

Management of hepatitis C patients by primary care physicians in the USA: results of a national survey (English)

1 reference

12 November 2017

0 references

1 reference

Shehab TM

1

1 reference

12 November 2017

Sonnad SS

series ordinal

2

1 reference

12 November 2017

Lok AS

series ordinal

3

1 reference

12 November 2017

publication date

1 September 2001

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

8

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

377-383

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

The challenge of defining and counting generalist physicians: an analysis of Physician Masterfile data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

Management of hepatitis C: a national survey of gastroenterologists and hepatologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

The effect of race and sex on physicians' recommendations for cardiac catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

Lying for patients: physician deception of third-party payers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00310.X

10.1046/J.1365-2893.2001.00310.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference